Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Vascular Calcification | 6 | 2018 | 396 | 1.89 | Why? |
| Muscle, Smooth, Vascular | 3 | 2018 | 86 | 1.54 | Why? |
| Membranes, Artificial | 2 | 2017 | 175 | 1.16 | Why? |
| Myocytes, Smooth Muscle | 4 | 2018 | 127 | 1.12 | Why? |
| Uremia | 2 | 2018 | 50 | 0.90 | Why? |
| Osteoblasts | 2 | 2018 | 87 | 0.74 | Why? |
| Thrombelastography | 2 | 2021 | 627 | 0.72 | Why? |
| Hemodialysis Solutions | 1 | 2017 | 18 | 0.70 | Why? |
| Renal Dialysis | 5 | 2018 | 4358 | 0.67 | Why? |
| Fibrinolysis | 1 | 2020 | 521 | 0.60 | Why? |
| Kidney Failure, Chronic | 4 | 2018 | 3222 | 0.53 | Why? |
| Thromboembolism | 2 | 2021 | 2101 | 0.43 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.34 | Why? |
| Inflammation | 4 | 2021 | 13255 | 0.29 | Why? |
| Interleukin-6 | 2 | 2018 | 7522 | 0.25 | Why? |
| Viscoelastic Substances | 1 | 2020 | 13 | 0.23 | Why? |
| Cross-Over Studies | 3 | 2021 | 867 | 0.21 | Why? |
| Cells, Cultured | 4 | 2018 | 5835 | 0.20 | Why? |
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2018 | 29 | 0.19 | Why? |
| Immediate-Early Proteins | 1 | 2018 | 44 | 0.19 | Why? |
| Proto-Oncogene Proteins c-fos | 1 | 2018 | 50 | 0.18 | Why? |
| Zinc Sulfate | 1 | 2018 | 35 | 0.18 | Why? |
| Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 92 | 0.18 | Why? |
| Transcription Factor AP-1 | 1 | 2018 | 75 | 0.18 | Why? |
| Dialysis Solutions | 1 | 2018 | 76 | 0.17 | Why? |
| Point-of-Care Systems | 2 | 2021 | 2955 | 0.17 | Why? |
| beta 2-Microglobulin | 1 | 2017 | 102 | 0.16 | Why? |
| Extracellular Matrix Proteins | 1 | 2017 | 95 | 0.16 | Why? |
| Calcium-Binding Proteins | 1 | 2017 | 121 | 0.16 | Why? |
| Osteopontin | 1 | 2017 | 96 | 0.16 | Why? |
| Blood Coagulation Tests | 1 | 2020 | 855 | 0.15 | Why? |
| Central Nervous System Diseases | 1 | 2020 | 410 | 0.15 | Why? |
| Cell Differentiation | 2 | 2018 | 1338 | 0.14 | Why? |
| Healthy Volunteers | 2 | 2018 | 1444 | 0.14 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 502 | 0.13 | Why? |
| NF-kappa B | 2 | 2018 | 1301 | 0.13 | Why? |
| In Vitro Techniques | 1 | 2017 | 1027 | 0.13 | Why? |
| Proteome | 1 | 2021 | 1812 | 0.11 | Why? |
| Blood Coagulation | 2 | 2021 | 2768 | 0.11 | Why? |
| Coronary Vessels | 1 | 2018 | 914 | 0.10 | Why? |
| Autoantibodies | 1 | 2020 | 2094 | 0.10 | Why? |
| Cell Transdifferentiation | 2 | 2018 | 47 | 0.09 | Why? |
| Monocytes | 2 | 2018 | 2978 | 0.09 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.09 | Why? |
| Blood Coagulation Disorders | 1 | 2021 | 2040 | 0.08 | Why? |
| Signal Transduction | 3 | 2018 | 7207 | 0.08 | Why? |
| Plasma | 1 | 2017 | 1809 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.08 | Why? |
| Venous Thrombosis | 1 | 2021 | 2739 | 0.08 | Why? |
| Cytokines | 2 | 2018 | 15010 | 0.07 | Why? |
| Female | 11 | 2021 | 380317 | 0.06 | Why? |
| Male | 10 | 2021 | 367725 | 0.06 | Why? |
| Lung | 2 | 2021 | 31049 | 0.06 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.06 | Why? |
| Pulmonary Embolism | 1 | 2021 | 4775 | 0.06 | Why? |
| Peripartum Period | 1 | 2021 | 89 | 0.05 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.05 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.05 | Why? |
| Enzyme Activation | 1 | 2021 | 425 | 0.05 | Why? |
| Humans | 16 | 2021 | 930598 | 0.05 | Why? |
| Anticoagulants | 1 | 2021 | 9563 | 0.05 | Why? |
| Anti-Inflammatory Agents | 1 | 2018 | 6153 | 0.05 | Why? |
| Mice, Knockout, ApoE | 1 | 2018 | 42 | 0.05 | Why? |
| Hydroxyethylrutoside | 1 | 2018 | 9 | 0.05 | Why? |
| Chondrogenesis | 1 | 2018 | 19 | 0.05 | Why? |
| Nephrocalcinosis | 1 | 2018 | 14 | 0.05 | Why? |
| Hyperphosphatemia | 1 | 2018 | 20 | 0.05 | Why? |
| Observer Variation | 1 | 2021 | 622 | 0.05 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Autoantigens | 1 | 2020 | 388 | 0.04 | Why? |
| Hydrazines | 1 | 2018 | 68 | 0.04 | Why? |
| Osteogenesis | 1 | 2018 | 95 | 0.04 | Why? |
| Phosphates | 1 | 2018 | 135 | 0.04 | Why? |
| Blood Gas Analysis | 1 | 2021 | 893 | 0.04 | Why? |
| Glucuronidase | 1 | 2018 | 103 | 0.04 | Why? |
| Gene Silencing | 1 | 2018 | 213 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2018 | 501 | 0.04 | Why? |
| Receptor, Angiotensin, Type 1 | 1 | 2018 | 160 | 0.04 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2018 | 9659 | 0.04 | Why? |
| Receptor, Angiotensin, Type 2 | 1 | 2018 | 190 | 0.04 | Why? |
| Angiotensin I | 1 | 2018 | 200 | 0.04 | Why? |
| Blood Cell Count | 1 | 2021 | 1101 | 0.04 | Why? |
| Benzamides | 1 | 2018 | 421 | 0.04 | Why? |
| Aorta | 1 | 2018 | 355 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2021 | 11559 | 0.04 | Why? |
| Nephrectomy | 1 | 2018 | 406 | 0.03 | Why? |
| Autoimmunity | 1 | 2020 | 841 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Aged | 5 | 2021 | 215776 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2021 | 3395 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.03 | Why? |
| Renal Insufficiency | 1 | 2018 | 810 | 0.03 | Why? |
| Zinc | 1 | 2018 | 817 | 0.03 | Why? |
| Proteomics | 1 | 2021 | 2481 | 0.03 | Why? |
| Adolescent | 2 | 2018 | 86841 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2018 | 10998 | 0.03 | Why? |
| Monitoring, Physiologic | 1 | 2021 | 1956 | 0.03 | Why? |
| Mice | 2 | 2018 | 21357 | 0.02 | Why? |
| Protein Kinase Inhibitors | 1 | 2018 | 1585 | 0.02 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Dietary Supplements | 1 | 2018 | 2251 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Ultrasonography | 1 | 2021 | 4409 | 0.02 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.02 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Animals | 2 | 2018 | 78931 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Infant | 1 | 2018 | 30274 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.01 | Why? |
| Pandemics | 1 | 2021 | 389249 | 0.00 | Why? |
Zickler's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(126)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(172)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_